F-0463-2024 Class III Terminated
FDA food recall F-0463-2024 was initiated by ActiPharma, Inc. on September 28, 2023 and is designated Class III. Reason for recall: FDA sample analysis of ACTIRON Dietary Supplement, 100 Tablets, Lot 13309, found the product did not meet folic acid specification compared to the label claim. The recall status is terminated (terminated January 16, 2024). Affected quantity: 607 bottles of 100 tablets each.
Recall Details
- Product Type
- Food
- Report Date
- November 29, 2023
- Initiation Date
- September 28, 2023
- Termination Date
- January 16, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 607 bottles of 100 tablets each
Product Description
ACTIRON Dietary Supplement, ActiPharma, 100 tablets (24 bottles per case) ) (Lot 13309, Exp.: 01/26), UPC: 363102217104.
Reason for Recall
FDA sample analysis of ACTIRON Dietary Supplement, 100 Tablets, Lot 13309, found the product did not meet folic acid specification compared to the label claim.
Distribution Pattern
Domestic distribution, in Puerto Rico.
Code Information
Lot 13309, Exp: 01/26